Basis of Presentation and Accounting Policies - Narrative (Details) $ in Thousands			3 Months Ended
	Dec. 19, 2025 USD ($) shares	Sep. 11, 2025 USD ($) shares	Mar. 31, 2026 USD ($) tranche	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($)	Sep. 09, 2025 closing
Convertible Preferred Stock and Stockholders' Deficit
Cash and cash equivalents			$ 99,209		$ 109,517
Working capital			85,600
Accumulated deficit			(310,487)		(292,156)
Net loss attributable to common stockholders			(18,331)	$ (12,433)
Net cash used in operating activities			(10,981)	$ (14,286)
Restricted cash			1,600		2,200
Restricted cash, current portion			$ 730		$ 1,346
Private Placement agreement, purchase of securities, number of tranches | tranche			2
Private Placement
Convertible Preferred Stock and Stockholders' Deficit
Sale of stock (in shares) | shares		26,717,414
Proceeds from sale of common stock and warrants		$ 46,700
Payments of stock and warrant issuance costs		$ 3,300
Private Placement | Prefunded Warrants, Liability
Convertible Preferred Stock and Stockholders' Deficit
Pre-funded warrants issued (in shares) | shares		6,003,758
Underwritten Offering | Leerink Partners LLC
Convertible Preferred Stock and Stockholders' Deficit
Issuance of common stock (in shares) | shares	5,000,000
Net proceeds received	$ 28,100
Issuance costs	$ 1,900
Maximum | Private Placement
Convertible Preferred Stock and Stockholders' Deficit
Number of sale of stock closings in transaction | closing						2